The advent of immunotherapy in oncology has led to the emergence of a new spectrum of adverse effects. A number of these have the potential to contribute to life-threatening outcomes; and therefore require prompt identification and aggressive treatment to optimise management. In this report, we describe a case of pembrolizumab-induced CTCAE (common toxicity criteria for adverse events) grade 4 myositis in a non-small cell lung cancer patient.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Singer PP, Jones GR. An unusual autoerotic fatality associated with chloroform inhalation. J Anal Toxicol 2006; 30: 216-218.
2. Gaillard Y, Masson-Seyer MF, Giroud M et al. A case of drugfacilitated sexual assault leading to death by chloroform poisoning. Int J Legal Med 2006; 120: 241-245.
3. Harada K, Ichiyama T, Ikeda H et al. An autopsy case of acute chloroform intoxication after intermittent inhalation for years. Nihon Hoigaku Zasshi 1997; 51: 319-323.
4. Greenblatt EP, Meng X. Divergence of volatile anesthetic effects in inhibitory neurotransmitter receptors. Anesthesiology 2001; 94: 1026-1033.
5. Flanagan RJ, Ruprah M, Meredith TJ et al. An introduction to the clinical toxicology of volatile substances. Drug Saf 1990; 5: 359-383.
6. Schroeder HG. Acute and delayed chloroform poisoning. A case report. Br J Anaesth 1965; 37: 971-975.
7. Kang YJ, Ahn J, Hwang YI. Acute liver injury in two workers exposed to chloroform in cleanrooms: a case report. Ann Occup Environ Med 2014; 26: 49.
8. Vlad IA, Armstrong J, Gault A. A painless burn: systemic toxicity after dermal exposure to chloroform. Emerg Med Australas 2014; 26: 648-649.
9. Environment Protection Agency (EPA). Chloroform. https://www.epa.gov/sites/production/f iles/2016-09/documents/chloroform.pdf
10. Gemma S, Ade P, Sbraccia M, Testai E et al. In vitro quantitative determination of phospholipid adducts of chloroform intermediates in hepatic and renal microsomes from different rodent strains. Environ Toxicol Pharmacol 1996; 2: 233-242.
11. Kalsi SS, Wood DM, Waring WS et al. Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose? Open Access Emerg Med 2011; 3: 69-76.
12. Lionte C. Lethal complications after poisoning with chloroform: case report and literature review. Hum Exp Toxicol 2010; 29: 615-622.
13. Kim H. A case of acute toxic hepatitis after suicidal chloroform and dichloromethane ingestion. Am J Emerg Med 2008; 26: 1073.e3-e6.
14. Jayaweera D, Islam S, Gunja N et al. Chloroform ingestion causing severe gastrointestinal injury, hepatotoxicity and dermatitis confirmed with plasma chloroform concentrations. Clin Toxicol 2017; 55: 147-150.
15. Sridhar N, Krishnakishore C, Sandeep Y et al. Chloroform poisoning: a case report. Ren Fail 2011; 33: 1037-1039.
16. Dell’Aglio DM, Sutter ME, Schwartz MD et al. Acute chloroform ingestion successfully treated with intravenously administered N-acetylcysteine. J Med Toxicol 2010; 6: 143-146.
17. Eyer F, Felgenhauer N, Murgan I et al. Delayed acute liver and renal failure after deliberate chloroform inhalation. Clin Toxicol 2011; 49: 208.
18. Oder M, Põld K. Oral chloroform poisoning. Clin Toxicol 2013;51: 320-321.
19. Olives TD, Regelman H, Lange R et al. Don’t DIY: youtube, chemistry, texts, and down home chloroform synthesis. Clin Toxicol 2016; 54: 740.
20. Waring WS. Onset and recovery of hepatic and renal injury after deliberate acute paracetamol overdose. BMJ Case Rep 2009; 2009pii: bcr08.2008.0806.
21. Ramachandran A, Visschers RGJ, Duan L et al. Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives. J Clin Transl Res 2018; 4: 75-100.
22. Reiter R, Burk RF. Formation of glutathione adducts of carbon tetrachloride metabolites in a rat liver microsomal incubation system. Biochem Pharmacol 1988; 37: 327-331.
23. Laurenzi RG, Locatelli C, Brucato A. N-Acetylcysteine: A proposal for therapy in acute poisoning due to highly hepatotoxic organic solvents. Vet Human Toxicol 1987; 29(Suppl 2): 95.
24. Waring WS. Novel acetylcysteine regimens for treatment of paracetamol overdose. Ther Adv Drug Saf 2012; 3: 305-315.
25. Kalsi SS, Dargan PI, Waring WS et al. A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose. Open Access Emerg Med 2011; 3: 87-96.
26. Rutter KJ, Ubhi T, Smith D et al. Reported dose as a measure of drug exposure after paracetamol overdose in children. Curr Clin Pharmacol 2013; 8: 164-168.